As regenerative medicine has grown, patients often ask an important question: are all stem cell sources the same? The short answer is no. Stem cells can come from several sources, including adipose tissue (fat), bone marrow, and birth-related tissues such as the umbilical cord. Each source has different characteristics, processing methods, and potential uses.
Understanding the Main Sources
Adipose-derived cells are collected from a patient’s own fat tissue. Bone marrow-derived
cells are obtained through marrow aspiration. Umbilical cord–derived amniotic
mesenchymal cells are sourced from donated birth tissues that would otherwise be
discarded after a healthy delivery.
Why Many Clinicians Favor Umbilical Cord–Derived Amniotic
Mesenchymal Cells
Many regenerative providers prefer amniotic mesenchymal cells from the umbilical cord
because they are associated with a youthful biologic profile and strong signaling activity.
Common reasons cited include:
• Fresh, early-life cellular origin rather than cells affected by decades of aging
• High concentration of regenerative signaling factors
• Strong communication signals that may support repair and recovery pathways
• No need for liposuction or bone marrow harvesting from the patient
• Consistent sourcing and preparation when obtained from reputable laboratories
• Often appealing for patients seeking a minimally invasive option
How They Compare With Adipose and Bone Marrow Sources
Autologous adipose and bone marrow approaches can be valuable in some settings, but cell
quality may vary based on age, health status, inflammation, and collection technique. They
also require harvesting tissue from the patient before treatment. For some individuals, that
added step is less desirable.
By contrast, umbilical cord–derived products are selected because they may provide a more
robust regenerative environment without a separate harvest procedure.
What This Means for Hair Restoration
In hair restoration, the goal is to support weakened follicles, improve the scalp
environment, and encourage stronger growth cycles. Many clinics choose umbilical cord–
derived amniotic mesenchymal therapies because they believe the signaling potential and
convenience make them especially well suited for this purpose.
Bottom Line
Not all stem cell sources are identical. While adipose and bone marrow therapies have roles
in regenerative medicine, many practitioners consider amniotic mesenchymal cells from the
umbilical cord a leading option because of their youthful origin, potent biologic activity,
high regenerative potential, and patient-friendly treatment experience. The best choice
should always be based on product quality, clinical judgment, and individual patient needs.
By Dr. Keith Kanto, PhD, ND, Trichologist
ReGen Therapeutics
6065 Roswell Rd.
Suite 580
Sandy Springs, GA 30328
